Literature DB >> 25194021

Functions of galectin-3 and its role in fibrotic diseases.

Liu-cheng Li1, Jun Li2, Jian Gao2.   

Abstract

Fibrotic diseases occur in a variety of organs and lead to continuous organ injury, function decline, and even failure. Currently effective treatment options are limited. Galectin-3 (Gal-3) is a pleiotropic lectin that plays an important role in cell proliferation, adhesion, differentiation, angiogenesis, and apoptosis. Accumulating evidence indicates that Gal-3 activates a variety of profibrotic factors, promotes fibroblast proliferation and transformation, and mediates collagen production. Recent studies have defined key roles for Gal-3 in fibrogenesis in diverse organ systems, including liver, kidney, lung, and myocardial. To help set the stage for future research, we review recent advances about the role played by Gal-3 in fibrotic diseases. Herein we discuss the potential profibrotic role of Gal-3, inhibition of which may represent a promising therapeutic strategy against tissue fibrosis.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25194021     DOI: 10.1124/jpet.114.218370

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  78 in total

1.  Identification of galectin-3 as an autoantigen in patients with IgG4-related disease.

Authors:  Cory A Perugino; Sultan B AlSalem; Hamid Mattoo; Emanuel Della-Torre; Vinay Mahajan; Gayathri Ganesh; Hugues Allard-Chamard; Zachary Wallace; Sydney B Montesi; Johannes Kreuzer; Wilhelm Haas; John H Stone; Shiv Pillai
Journal:  J Allergy Clin Immunol       Date:  2018-05-29       Impact factor: 10.793

2.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

3.  Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease.

Authors:  Yang Zhou; Chuan Hua He; Daniel S Yang; Tung Nguyen; Yueming Cao; Suchitra Kamle; Chang-Min Lee; Bernadette R Gochuico; William A Gahl; Barry S Shea; Chun Geun Lee; Jack A Elias
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

4.  Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT.

Authors:  Yu Akahoshi; Hideki Nakasone; Koji Kawamura; Machiko Kusuda; Shunto Kawamura; Junko Takeshita; Nozomu Yoshino; Yukiko Misaki; Kazuki Yoshimura; Ayumi Gomyo; Aki Tanihara; Masaharu Tamaki; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Blood Adv       Date:  2019-11-12

5.  Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.

Authors:  Naoki Tanaka; Shogo Takahashi; Xiao Hu; Yu Lu; Naoyuki Fujimori; Srujana Golla; Zhong-Ze Fang; Toshifumi Aoyama; Kristopher W Krausz; Frank J Gonzalez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-08-24       Impact factor: 5.187

Review 6.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

7.  Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.

Authors:  Pingping Li; Shuainan Liu; Min Lu; Gautum Bandyopadhyay; Dayoung Oh; Takeshi Imamura; Andrew M F Johnson; Dorothy Sears; Zhufang Shen; Bing Cui; Lijuan Kong; Shaocong Hou; Xiao Liang; Salvatore Iovino; Steven M Watkins; Wei Ying; Olivia Osborn; Joshua Wollam; Martin Brenner; Jerrold M Olefsky
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

Review 8.  Galectin-3 regulation of wound healing and fibrotic processes: insights for chronic skin wound therapeutics.

Authors:  Karrington McLeod; John T Walker; Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2018-01-25       Impact factor: 5.782

9.  Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.

Authors:  Olga Frunza; Ilaria Russo; Amit Saxena; Arti V Shinde; Claudio Humeres; Waqas Hanif; Vikrant Rai; Ya Su; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2016-03-03       Impact factor: 4.307

10.  Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.

Authors:  Wenhui Cui; Liucheng Li; Delin Li; Xiaoting Mo; Wencheng Zhou; Zhihui Zhang; Liang Xu; Ping Zhao; Lianwen Qi; Ping Li; Jian Gao
Journal:  Inflamm Res       Date:  2015-09-28       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.